Brassicasterol inhibits hepatitis B virus-associated hepatocellular carcinoma development via suppression of AKT signaling pathway
出版年份 2023 全文链接
标题
Brassicasterol inhibits hepatitis B virus-associated hepatocellular carcinoma development via suppression of AKT signaling pathway
作者
关键词
-
出版物
Infectious Agents and Cancer
Volume 18, Issue 1, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2023-04-20
DOI
10.1186/s13027-023-00502-1
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Adult Hepatitis B Virus Vaccination Coverage in China from 2011 to 2021: A Systematic Review
- (2022) Xinxin Bai et al. Vaccines
- Hepatitis B virus induces sorafenib resistance in liver cancer via upregulation of cIAP2 expression
- (2021) Shouhua Zhang et al. Infectious Agents and Cancer
- The novel antiviral properties of brassicasterol against human adenovirus
- (2021) Peifeng Yu et al. Future Virology
- Immunotherapies for hepatocellular carcinoma
- (2021) Josep M. Llovet et al. Nature Reviews Clinical Oncology
- Epidemiology and surveillance for hepatocellular carcinoma: New trends
- (2020) Amit G. Singal et al. JOURNAL OF HEPATOLOGY
- HSV-2 Infection of Human Genital Epithelial Cells Upregulates TLR9 Expression Through the SP1/JNK Signaling Pathway
- (2020) Kai Hu et al. Frontiers in Immunology
- Epidemiology of Hepatocellular Carcinoma
- (2020) Katherine A. McGlynn et al. HEPATOLOGY
- Inhibitory effect of ergosterol on bladder carcinogenesis is due to androgen signaling inhibition by brassicasterol, a metabolite of ergosterol
- (2020) Yasuharu Yazawa et al. Journal of Natural Medicines
- Bufalin inhibits hepatitis B virus-associated hepatocellular carcinoma development through androgen receptor dephosphorylation and cell cycle-related kinase degradation
- (2020) Zhuo Yu et al. CELLULAR ONCOLOGY
- Brassicasterol with Dual Anti-Infective Properties against HSV-1 and Mycobacterium tuberculosis, and Cardiovascular Protective Effect: Nonclinical In Vitro and In Silico Assessments
- (2020) Sherif T. S. Hassan Biomedicines
- Brassicasterol from Edible Aquacultural Hippocampus abdominalis Exerts an Anti-Cancer Effect by Dual-Targeting AKT and AR Signaling in Prostate Cancer
- (2020) Yinzhu Xu et al. Biomedicines
- AKT as a Therapeutic Target for Cancer
- (2019) Mengqiu Song et al. CANCER RESEARCH
- Lenvatinib: A Review in Hepatocellular Carcinoma
- (2019) Zaina T. Al-Salama et al. DRUGS
- Akt in cancer: Mediator and more
- (2019) Sundaramoorthy Revathidevi et al. SEMINARS IN CANCER BIOLOGY
- Animal Models of Hepatocellular Carcinoma: The Role of Immune System and Tumor Microenvironment
- (2019) Zuzana Macek Jilkova et al. Cancers
- Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial
- (2018) Masatoshi Kudo et al. LANCET
- Challenges to a Cure for HBV Infection
- (2017) Barbara Testoni et al. SEMINARS IN LIVER DISEASE
- Hepatocellular carcinoma
- (2016) Josep M. Llovet et al. Nature Reviews Disease Primers
- Linifanib Versus Sorafenib in Patients With Advanced Hepatocellular Carcinoma: Results of a Randomized Phase III Trial
- (2015) Calin Cainap et al. JOURNAL OF CLINICAL ONCOLOGY
- Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013
- (2015) Aparna Schweitzer et al. LANCET
- Risk factors for hepatocellular carcinoma in patients with drug-resistant chronic hepatitis B
- (2013) Chung Hwan Jun WORLD JOURNAL OF GASTROENTEROLOGY
- Chronic hepatitis B infection in adolescents who received primary infantile vaccination
- (2012) Tzu-Wei Wu et al. HEPATOLOGY
- Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma: Subanalyses of a phase III trial
- (2012) Jordi Bruix et al. JOURNAL OF HEPATOLOGY
- The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data: Figure 1.
- (2012) Ethan Cerami et al. Cancer Discovery
- The plant sterol brassicasterol as additional CSF biomarker in Alzheimer’s disease
- (2011) T. Vanmierlo et al. ACTA PSYCHIATRICA SCANDINAVICA
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search